Research Shows How T-cells Are Blocked from Fighting Cancer

Research Shows How T-cells Are Blocked from Fighting Cancer Researchers at Salk Institute have uncovered a key insight about how oxidized fat molecules inhibit T-cells from killing cancer cells. Their recent discovery, which was published in the peer-reviewed journal Immunity, discusses ways to make sure the immune system can effectively

New Alzheimer’s Treatment Targets Identified

New Alzheimer’s Treatment Targets Identified A research team at Washington University School of Medicine in St. Louis has identified potential new treatment targets for Alzheimer’s disease, as well as existing drugs that have therapeutic potential against these targets. Read more...

COVID and the Brain: Researchers Zero in on How Damage Occurs

COVID and the Brain: Researchers Zero in on How Damage Occurs How COVID-19 damages the brain is becoming clearer. New evidence suggests that the coronavirus’s assault on the brain could be multipronged: it might attack certain brain cells directly, reduce blood flow to brain tissue or trigger production of immune

Cell-Based Immunotherapy Shows Promise Against Melanoma

Cell-Based Immunotherapy Shows Promise Against Melanoma An immunotherapy based on supercharging the immune system’s natural killer cells has been effective in treating patients with recurrent leukemia and other difficult to treat blood cancers. Now, researchers at Washington University School of Medicine in St. Louis have shown in preclinical studies conducted

Landmark Alzheimer’s Drug Approval Confounds Research Community

Landmark Alzheimer’s Drug Approval Confounds Research Community The US Food and Drug Administration (FDA) approval yesterday of the first new drug for Alzheimer’s disease in 18 years was welcomed by some people looking for hope against an intractable condition. But, for many researchers, it came as a surprise — and